{"id":"av5080","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"AV5080 is a broad-spectrum antiviral nucleoside that targets the RNA polymerase of enveloped RNA viruses. By incorporating into viral RNA during replication, it causes chain termination and prevents viral genome synthesis. This mechanism provides activity against multiple viral families including flaviviruses and other RNA viruses.","oneSentence":"AV5080 is a nucleoside analog that inhibits viral RNA-dependent RNA polymerase, blocking replication of RNA viruses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:03:00.284Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tick-borne encephalitis (TBE)"},{"name":"Other flaviviral infections"}]},"trialDetails":[{"nctId":"NCT05095545","phase":"PHASE2","title":"Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza","status":"COMPLETED","sponsor":"Viriom","startDate":"2017-11-13","conditions":"Influenza","enrollment":135},{"nctId":"NCT05093998","phase":"PHASE3","title":"Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza","status":"UNKNOWN","sponsor":"Viriom","startDate":"2022-01-15","conditions":"Influenza","enrollment":700}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["AV5080 at a daily dose of 160 mg"],"phase":"phase_3","status":"active","brandName":"AV5080","genericName":"AV5080","companyName":"Viriom","companyId":"viriom","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AV5080 is a nucleoside analog that inhibits viral RNA-dependent RNA polymerase, blocking replication of RNA viruses. Used for Tick-borne encephalitis (TBE), Other flaviviral infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}